Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Sansevieria trifasciata Prain shows promise for treating hair loss by inhibiting androgen receptors.

Hair loss may increase heart disease risk.

Hormone treatment caused hair loss, finasteride helped regrowth.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Both estrogens and androgens are important for health in both males and females.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.